Eli Lilly taps Fujifilm to chip in on COVID-19 antibody manufacturing as it awaits FDA's emergency use decision

Shortly after rolling out interim data on its COVID-19 antibody hopeful, Eli Lilly last week sent the therapy ahead to the FDA for a potential emergency nod. If the antibody crosses the finish line, Lilly can expect a huge surge in demand—and it's bringing in a manufacturing partner to help out.